Frontiers in Oncology | Pharmacology of Anti-Cancer Drugs

Case Report

Published on 24 Oct 2023

Case Report: Serum methotrexate monitoring by immunoassay: confusion by by-product, confusion by antidote

in Pharmacology of Anti-Cancer Drugs

Aditya Sharma
Philip Benoit
Frederick Lansigan
David Nierenberg

Frontiers in Oncology

doi 10.3389/fonc.2023.1237178

1,817 views
2 citations

Brief Research Report

Published on 24 Oct 2023

Acute low back pain as infusion-related reaction to monoclonal antibodies

in Pharmacology of Anti-Cancer Drugs

Pawel Majenka
Carmen Loquai
Tilman Schöning
Alexander Enk
Jessica Hassel

Frontiers in Oncology

doi 10.3389/fonc.2023.1161818

5,814 views
2 citations

Original Research

Published on 23 Oct 2023

Next-generation sequencing identifies CDKN2A alterations as prognostic biomarkers in recurrent or metastatic head and neck squamous cell carcinoma predominantly receiving immune checkpoint inhibitors

in Pharmacology of Anti-Cancer Drugs

Liqiong Xue
Wenbo Tang
Jiuli Zhou
Junli Xue
Qun Li
Xiaoxiao Ge
Fengjuan Lin
Wei Zhao
Ye Guo

Frontiers in Oncology

doi 10.3389/fonc.2023.1276009

2,591 views
10 citations

Review

Published on 23 Oct 2023

The transmembrane proteins (TMEM) and their role in cell proliferation, migration, invasion, and epithelial-mesenchymal transition in cancer

in Pharmacology of Anti-Cancer Drugs

Gloria Angelina Herrera-Quiterio
Sergio Encarnación-Guevara

Frontiers in Oncology

doi 10.3389/fonc.2023.1244740

9,723 views
12 citations

Opinion

Published on 09 Oct 2023

From bench to bedside, 2-in-1 design expedites phase 2/3 oncology drug development

in Pharmacology of Anti-Cancer Drugs

Cong Chen
Xuekui Zhang

Frontiers in Oncology

doi 10.3389/fonc.2023.1251672

2,152 views
2 citations

Review

Published on 09 Oct 2023

Natural polysaccharides exert anti-tumor effects as dendritic cell immune enhancers

in Pharmacology of Anti-Cancer Drugs

Hongtai Xiong
Xinpu Han
Liu Cai
Honggang Zheng

Frontiers in Oncology

doi 10.3389/fonc.2023.1274048

3,908 views
7 citations

Study Protocol

Published on 29 Sep 2023

Effects of imipramine on cancer patients over-expressing Fascin1; description of the HITCLIF clinical trial

in Pharmacology of Anti-Cancer Drugs

Antonio Asensi-Cantó
Edith Rodríguez-Braun
Asunción Beltrán-Videla
Ana María Hurtado
Pablo Conesa-Zamora

Frontiers in Oncology

doi 10.3389/fonc.2023.1238464

1,693 views
4 citations

Original Research

Published on 27 Sep 2023

177Lu-labeled PSMA targeting therapeutic with optimized linker for treatment of disseminated prostate cancer; evaluation of biodistribution and dosimetry

in Pharmacology of Anti-Cancer Drugs

Ayman Abouzayed
Kamila Seitova
Fanny Lundmark
Vitalina Bodenko
Maryam Oroujeni
Vladimir Tolmachev
Ulrika Rosenström
Anna Orlova

Frontiers in Oncology

doi 10.3389/fonc.2023.1221103

5,793 views
3 citations

Case Report

Published on 22 Sep 2023

Case Report: A rare case of non-small cell lung cancer with STRN-ALK fusion in a patient in very poor condition treated with first-line ensartinib

in Pharmacology of Anti-Cancer Drugs

Guo-qiang Song
Yi-zhong Li
Weiliang Kong
Guo-qiang Hu

Frontiers in Oncology

doi 10.3389/fonc.2023.1235679

2,213 views
2 citations

Original Research

Published on 05 Sep 2023

Prognostic and therapeutic implications of iron-related cell death pathways in acute myeloid leukemia

in Pharmacology of Anti-Cancer Drugs

Tongyu Li
Tongtong Lin
Jiahao Zhu
Miao Zhou
Shufang Fan
Hao Zhou
Qitian Mu
Lixia Sheng
Guifang Ouyang

Frontiers in Oncology

doi 10.3389/fonc.2023.1222098

2,497 views

Original Research

Published on 29 Aug 2023

Cell cycle arrest and apoptotic studies of Terminalia chebula against MCF-7 breast cancer cell line: an in vitro and in silico approach

in Pharmacology of Anti-Cancer Drugs

Pruthvish Reddy
Sushma Pradeep
Gopinath S. M.
Chandan Dharmashekar
Disha G.
Sai Chakith M. R.
Chandrashekar Srinivasa
Ali A. Shati
Mohammad Y. Alfaifi
Serag Eldin I. Elbehairi

Frontiers in Oncology

doi 10.3389/fonc.2023.1221275

4,448 views
1 citation

Original Research

Published on 28 Aug 2023

High quantum efficiency ruthenium coordination complex photosensitizer for improved radiation-activated Photodynamic Therapy

in Pharmacology of Anti-Cancer Drugs

Abul Kalam Azad
Lothar Lilge
Nawaid H. Usmani
John D. Lewis
Houston D. Cole
Colin G. Cameron
Sherri A. McFarland
Deepak Dinakaran
Ronald B. Moore

Frontiers in Oncology

doi 10.3389/fonc.2023.1244709

2,772 views
2 citations

Correction

Published on 25 Aug 2023

Corrigendum: Discovery of spirooxindole-derived small-molecule compounds as novel HDAC/MDM2 dual inhibitors and investigation of their anticancer activity

in Pharmacology of Anti-Cancer Drugs

Qian Zhao
Shan-Shan Xiong
Can Chen
Hong-Ping Zhu
Xin Xie
Cheng Peng
Gu He
Bo Han

Frontiers in Oncology

doi 10.3389/fonc.2023.1259550

1,108 views

Correction

Published on 25 Aug 2023

Corrigendum: Correlation analysis of MRD positivity in patients with completely resected stage I-IIIA non-small cell lung cancer: a cohort study

in Pharmacology of Anti-Cancer Drugs

Daling Dong
Shixin Zhang
Bin Jiang
Wei Wei
Chao Wang
Qian Yang
Tingzhi Yan
Min Chen
Liken Zheng
Weikang Shao

Frontiers in Oncology

doi 10.3389/fonc.2023.1275851

1,035 views

Editorial

Published on 23 Aug 2023

Editorial: Pharmaceutically targeting hypoxia in the breast cancer microenvironment: mechanistic and translational approaches

in Pharmacology of Anti-Cancer Drugs

Manjari Singh
Manash K. Paul
Subhadeep Roy

Frontiers in Oncology

doi 10.3389/fonc.2023.1265523

1,089 views

Original Research

Published on 21 Aug 2023

COVID−19 hospitalization increases the risk of developing glioblastoma: a bidirectional Mendelian-randomization study

in Pharmacology of Anti-Cancer Drugs

Jiajun Dong
Shengnan Wang
Haoqun Xie
Yanhao Mou
Hao Zhu
Yilong Peng
Jianxin Xi
Minggu Zhong
Zhengyuan Xie
Zongyuan Jiang

Frontiers in Oncology

doi 10.3389/fonc.2023.1185466

10,927 views
6 citations